T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	DISO 1024 1065	Hepatitis aguda o crónica por virus B o C
T3	ANAT 93 98	semen
#2	AnnotatorNotes T3	C0036614; Seminal fluid; Body Substance | C2756969; Semen; Body Substance
T4	PROC 136 163	tratamiento antirretroviral
#3	AnnotatorNotes T4	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T5	PROC 198 234	Ensayo clínico fase II, aleatorizado
T6	CHEM 286 312	fármacos antirretrovirales
#4	AnnotatorNotes T6	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T7	ANAT 337 351	plasma seminal
T8	DISO 369 389	infección por el VIH
#5	AnnotatorNotes T8	C0019693; HIV Infections; Disease or Syndrome
T9	PROC 394 405	tratamiento
#6	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 437 456	Infección por VIH-1
#7	AnnotatorNotes T10	C2363741; HIV-1 infection; Disease or Syndrome
T11	DISO 486 505	Infección por VIH-1
#8	AnnotatorNotes T11	C2363741; HIV-1 infection; Disease or Syndrome
T12	PROC 535 562	tratamiento antirretroviral
#9	AnnotatorNotes T12	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T13	PROC 631 644	Valor de CD4+
#10	AnnotatorNotes T13	C0243009; CD4+ Lymphocyte Count; Laboratory Procedure
T14	ANAT 589 599	plasmático
#11	AnnotatorNotes T14	C0032105; Plasma; Body Substance
T15	ANAT 640 644	CD4+
#12	AnnotatorNotes T15	C0039215; CD4 Positive T Lymphocytes; Cell
T16	PROC 656 688	Test de resistencias genotípicas
#13	AnnotatorNotes T16	C0877124; Genotype drug resistance test; Laboratory Procedure
T17	CHEM 710 729	fármacos en estudio
#14	AnnotatorNotes T17	C0013230; Investigational New Drugs; Pharmacologic Substance
T18	PROC 734 770	Consentimiento informado por escrito
#15	AnnotatorNotes T18	C0811741; Obtain informed written consent; Health Care Activity
T19	PROC 813 845	Test de resistencias genotípicas
#16	AnnotatorNotes T19	C0877124; Genotype drug resistance test; Laboratory Procedure
T20	CHEM 867 886	fármacos en estudio
#17	AnnotatorNotes T20	C0013230; Investigational New Drugs; Pharmacologic Substance
T21	PROC 1401 1425	consentimiento informado
#18	AnnotatorNotes T21	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T22	DISO 890 914	Infecciones oportunistas
#19	AnnotatorNotes T22	C0029118; Opportunistic Infections; Disease or Syndrome
T23	DISO 925 935	neoplasias
#20	AnnotatorNotes T23	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T24	DISO 940 948	Síntomas
#21	AnnotatorNotes T24	C1457887; Symptoms; Sign or Symptom
T25	DISO 952 983	infección de transmisión sexual
#22	AnnotatorNotes T25	C0036916; Sexually Transmitted Diseases; Disease or Syndrome
T26	DISO 1069 1086	Cirrosis hepática
#23	AnnotatorNotes T26	C0023890; Liver Cirrhosis; Disease or Syndrome
T27	PROC 1238 1264	Aclaramiento de creatinina
#24	AnnotatorNotes T27	C0373595; Creatinine clearance measurement; Laboratory Procedure
T28	CHEM 1313 1323	medicación
#25	AnnotatorNotes T28	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T29	PROC 75 98	carga viral en el semen
T30	DISO 112 115	VIH
#26	AnnotatorNotes T30	C0458074; Human immunodeficiency virus (HIV) status; Finding
T31	CHEM 148 163	antirretroviral
#27	AnnotatorNotes T31	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T32	CHEM 547 562	antirretroviral
#28	AnnotatorNotes T32	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T33	PROC 573 599	Carga viral VIH plasmático
T34	DISO 693 703	mutaciones
#29	AnnotatorNotes T34	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T35	DISO 850 860	mutaciones
#30	AnnotatorNotes T35	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T36	ANAT 1078 1086	hepática
#31	AnnotatorNotes T36	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T37	CHEM 1254 1264	creatinina
#32	AnnotatorNotes T37	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T38	Date 13 17	2014
T39	LIVB 102 111	pacientes
#33	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T41	Neg_cue 120 122	no
T44	LIVB 355 364	pacientes
#34	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Neg_cue 390 393	sin
T46	Age 517 526	> 18 años
T47	Neg_cue 531 534	Sin
T48	LIVB 585 588	VIH
#35	AnnotatorNotes T48	C0019682; HIV; Virus
T51	Neg_cue 689 692	sin
T52	LIVB 775 783	paciente
#36	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T55	Duration 1042 1049	crónica
#37	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	LIVB 1054 1065	virus B o C
#38	AnnotatorNotes T56	C0019169; hepatitis B virus; Virus + C0220847; hepatitis C virus; Virus
T60	Neg_cue 1336 1352	Imposibilidad de
T61	Neg_cue 1388 1400	Retirada del
T62	LIVB 81 86	viral
#39	AnnotatorNotes T62	C0042776; Virus; Virus
T63	LIVB 386 389	VIH
#40	AnnotatorNotes T63	C0019682; HIV; Virus
T64	LIVB 579 584	viral
#41	AnnotatorNotes T64	C0042776; Virus; Virus
T40	LIVB 451 456	VIH-1
#42	AnnotatorNotes T40	C0019704; HIV-1; Virus
T42	LIVB 500 505	VIH-1
#43	AnnotatorNotes T42	C0019704; HIV-1; Virus
T43	LIVB 509 516	Varones
#44	AnnotatorNotes T43	C0025266; Male population group; Population Group
T50	PROC 1353 1371	seguir las visitas
#45	AnnotatorNotes T50	C0589121; Follow-up visit; Health Care Activity
T53	PROC 1124 1134	Child Pugh
#46	AnnotatorNotes T53	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
A1	Assertion T4 Negated
A2	Assertion T31 Negated
A3	Assertion T9 Negated
A4	Assertion T12 Negated
A5	Assertion T32 Negated
A6	Assertion T34 Negated
A7	Assertion T50 Negated
A8	Assertion T21 Negated
A9	Status T4 History_of
A10	Status T31 History_of
A11	Status T9 History_of
A12	Status T12 History_of
A13	Status T32 History_of
#47	AnnotatorNotes T5	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity
#48	AnnotatorNotes T7	C0242499; Seminal plasma (substance); Body Substance
T49	Neg_cue 1288 1290	No
T54	Observation 1291 1323	cumplimentación de la medicación
A14	Assertion T54 Negated
#49	AnnotatorNotes T54	C2364172; Adherence To Medication Regime; Finding
T57	Observation 1162 1186	Anomalias de laboratorio
#50	AnnotatorNotes T57	C3648370; laboratory tests nonspecific abnormal findings; Finding
T58	Quantifier_or_Qualifier 1187 1198	grado 3 o 4
R1	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T58	
T59	Result_or_Value 1087 1100	estadio B o C
R2	Has_Result_or_Value Arg1:T53 Arg2:T59	
R3	Location_of Arg1:T36 Arg2:T26	
R4	Causes Arg1:T56 Arg2:T2	
R5	Has_Duration_or_Interval Arg1:T2 Arg2:T55	
R6	Causes Arg1:T25 Arg2:T24	
T65	Quantifier_or_Qualifier 984 990	activa
#51	AnnotatorNotes T65	C0679217; Active State; Idea or Concept
R7	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T65	
T66	Quantifier_or_Qualifier 915 922	activas
#52	AnnotatorNotes T66	C0679217; Active State; Idea or Concept
R8	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T66	
T67	CONC 1011 1020	inclusión
#53	AnnotatorNotes T67	C1512693; Inclusion; Qualitative Concept
R9	Overlap Arg1:T24 Arg2:T67	
R10	Overlap Arg1:T25 Arg2:T67	
R12	Negation Arg1:T51 Arg2:T34	
T68	Result_or_Value 1273 1283	<70 ml/min
R14	Has_Result_or_Value Arg1:T27 Arg2:T68	
R15	Location_of Arg1:T3 Arg2:T29	
R16	Experiences Arg1:T39 Arg2:T29	
R17	Experiences Arg1:T39 Arg2:T30	
R18	Causes Arg1:T62 Arg2:T30	
R19	Negation Arg1:T41 Arg2:T4	
R20	Used_for Arg1:T31 Arg2:T4	
R21	Experiences Arg1:T39 Arg2:T4	
R22	Experiences Arg1:T44 Arg2:T8	
R23	Experiences Arg1:T44 Arg2:T6	
R24	Causes Arg1:T63 Arg2:T8	
R25	Negation Arg1:T45 Arg2:T9	
R26	Experiences Arg1:T44 Arg2:T9	
R27	Causes Arg1:T40 Arg2:T10	
R28	Causes Arg1:T42 Arg2:T11	
R29	Has_Age Arg1:T43 Arg2:T46	
R30	Negation Arg1:T47 Arg2:T12	
R31	Used_for Arg1:T32 Arg2:T12	
R32	Negation Arg1:T47 Arg2:T32	
T69	Result_or_Value 600 627	≥1.000 y <100.000 copias/ml
R33	Location_of Arg1:T14 Arg2:T33	
R34	Has_Result_or_Value Arg1:T33 Arg2:T69	
T70	Result_or_Value 645 652	≥200/μl
R35	Has_Result_or_Value Arg1:T13 Arg2:T70	
R36	Negation Arg1:T49 Arg2:T54	
R37	Negation Arg1:T60 Arg2:T50	
R38	Negation Arg1:T61 Arg2:T21	
T71	Quantifier_or_Qualifier 1372 1383	programadas
#54	AnnotatorNotes T71	C0205539; Scheduled - procedure status; Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T71	
A15	Assertion T71 Negated
R40	Negation Arg1:T60 Arg2:T71	
A16	Experiencer T52 Patient
A17	Experiencer T39 Patient
A18	Experiencer T44 Patient
A19	Experiencer T43 Patient
